BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 2, 2005
View Archived Issues
Gabexate mesilate tested for therapeutic potential in gut hypoperfusion
Read More
MG-132 modulates cytokine response and mortality in preclinical sepsis model
Read More
Protective effects of green tea polyphenols against acetaminophen-induced liver damage
Read More
Novasome delivery of H2 antagonists shows promise for periodontal disease
Read More
Pharmacokinetics and tissue distribution of fumitremorgin C in tumor-bearing mice
Read More
Icos and Solvay to copromote AndroGel
Read More
Priority review for Tygacil NDA
Read More
YM Biosciences and Shin Poong Pharmaceutical partner for tesmilifene
Read More
Neose and BioGeneriX enter option agreement for GlycoPEGylation technology
Read More
Access updates recent developments
Read More
Lilly withdraws duloxetine NDA for stress urinary incontinence
Read More
Enrollment begins in phase II study of MS-I.E.T.
Read More
Northwest to begin phase III trial of DCVax-Prostate
Read More
New indications approved for Neoral and Sandimmun in Japan
Read More
Preclinical targeting of B-cell lymphoma using the humanized monoclonal antibody CMC-544
Read More
Aromatization reported to increase the cognitive benefits of testosterone supplementation
Read More
Phase II data on the benefits of Acclaim in chronic stable angina
Read More
Antirheumatic effects of MMP inhibitor in adjuvant-induced arthritis model
Read More
Chronic blockade of ETB receptors exacerbates degeneration of cardiomyocytes
Read More
Ajinomoto patents TRPV receptor ligands for treatment of pain
Read More
New compounds for immune-mediated diseases designed at Merck
Read More
OSI scientists develop new glycogen phosphorylase inhibitors
Read More
Integrin antagonists in early development at Genentech
Read More
Calcium channel blockers emerge from NeuroMed R&D
Read More
Guilford discloses new PARP inhibitors
Read More
RDP-58 active in model of interstitial cystitis
Read More